Telix Pharmaceuticals LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Telix Pharmaceuticals MD & Group CEO Christian Behrenbruch acquired 67,935 shares, signaling strong internal confidence in the company's trajectory.
NASDAQ
Telix Pharmaceuticals Ltd's Group CFO, Darren Charlton Smith, acquired 1,111 ordinary shares through the exercise of vested share rights.